Study at a glance
How was vitamin D studied in tissue renewal and recovery?
This review compares cell experiments, animal repair studies and human fracture trials. It asks whether vitamin D-related compounds influence tissue renewal and recovery. The compounds, doses, timing and cell states differed, so the studies did not test one common treatment.
Did vitamin D compounds help wounds, teeth or muscles recover?
In mice, an intermediate dose of active vitamin D injected around wounds gave the strongest closure result; the lowest dose did not clearly help. Dental-cell experiments improved selected markers but did not measure repaired teeth or long-term function. Muscle-cell responses also depended on surrounding signals and the vitamin D compound. A favourable marker did not establish recovery of injured muscle.
Did the form and timing of vitamin D affect bone repair in mice?
Early local active-vitamin-D treatment impaired fracture repair in mice with enough vitamin D despite reducing selected inflammatory signals. Later treatment did not improve overall healing, although one bone-structure measure increased. Separate animal work supported a repair pathway involving a different substance made when the body processes vitamin D. Those results did not establish effectiveness in people.
Did vitamin D help broken bones heal in people?
Findings were mixed. Vita-Shock’s planned comparisons using patient assessments and X-rays found no clear benefit. A small trial using large, infrequent doses found unfavourable changes in selected estimates of bone strength without a benefit in patients’ ratings of their wrists. Another small trial reported faster average fracture joining with a weekly treatment schedule, but the proportions whose bones had healed at the final assessment did not clearly differ and reporting weaknesses reduced confidence. The evidence does not identify a better dose or show that vitamin D universally speeds recovery.
Read the full article below ↓Vitamin D-related compounds can influence regenerative signalling, but the effect depends on cell state, metabolite and timing. Laboratory markers, animal repair and human recovery are different levels of evidence. The selected studies do not establish a universal clinical regeneration benefit. Vitamin D, Regenerative Signalling and the Limits of Repair: Full Evidence Review.
Progenitor-associated signalling
Yan and colleagues tested peri-wound calcitriol injections in mice and related epidermal-cell experiments. The intermediate dose gave the strongest closure signal; the lowest dose did not significantly improve closure. PI3K inhibition supported pathway involvement, but cell markers were not lineage tracing and the treatment was injected rather than topical.
Song and colleagues studied human-origin dental pulp cells exposed to an inflammatory stimulus. Calcitriol improved selected inflammatory and alkaline-phosphatase-associated outcomes, while IL1beta protein was null. Actual mineralisation, repaired teeth and long-term tissue function were not measured. These findings inform Vitamin D and Cell Differentiation, not a proven clinical regeneration treatment.
Enablers and limits
Muscle fibroblast and C2C12 studies showed that TGF-beta signalling, differentiation stage and vitamin D metabolite changed the response. Selected antifibrotic or myogenic markers did not establish recovery of injured muscle. The papers came from the same programme, rather than independent laboratories.
Wasnik and colleagues found that early local calcitriol suppressed M1-associated macrophage signals but impaired fracture repair in vitamin-D-sufficient mice. Later treatment did not improve overall healing, although one trabecular measure increased. Suppressing inflammation is therefore not automatically helpful at every stage.
Martineau’s related animal studies supported a distinct 24R,25-dihydroxyvitamin D3/FAM57B2/lactosylceramide route and selected improvements in wild-type fracture biomechanics. These were complementary preclinical experiments, with limited safety observation and no human efficacy result.
Human fracture studies were mixed. Vita-Shock’s prespecified clinical and radiographic comparisons were null. Heyer’s small bolus-dose trial found adverse changes in selected estimated mechanical outcomes but no patient-rated wrist benefit. Selvaraj’s small trial reported faster mean union with a weekly regimen, but final union proportions were not significantly different and reporting weaknesses limited confidence. The regimens are research comparisons, not dosing advice.
These results connect Vitamin D and Tissue Repair with the wider physiology of Vitamin D and Regeneration. They do not establish mitochondrial mediation or reversal of senescence, separate topics covered by Vitamin D and Mitochondrial Function and Vitamin D and Cellular Senescence.
Conclusion
The evidence supports context-dependent effects on regenerative biology. It does not show that a favourable marker, a higher dose or a more anti-inflammatory cell profile necessarily produces better tissue recovery in people.
Original research
Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 58: e14121. DOI: 10.1590/1414-431x2025e14121. PMID: 40053036.
Srikuea R et al. 2023. TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis. Scientific reports. 13(1): 13811. DOI: 10.1038/s41598-023-40978-w. PMID: 37612333.
Watcharanapapan W et al. 2025. Regulatory role of vitamin D3 on myogenesis and fibrogenesis under Vdr gene silencing and TGF-β1 stimulation in skeletal muscle cells. Scientific reports. 15(1): 41599. DOI: 10.1038/s41598-025-25496-1. PMID: 41286086.
Song SE et al. 2026. Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells. Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds.2025.07.3564. PMID: 42689044.
Wasnik S et al. 2018. 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI insight. 3(17): e98773. DOI: 10.1172/jci.insight.98773. PMID: 30185660.
Slobogean GP et al. 2023. Effect of Vitamin D3 Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double-Blind Controlled Trial. JBMR plus. 7(1): e10705. DOI: 10.1002/jbm4.10705. PMID: 36699638.
Heyer FL et al. 2021. The Effect of Bolus Vitamin D3 Supplementation on Distal Radius Fracture Healing: A Randomized Controlled Trial Using HR-pQCT. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 36(8): 1492. DOI: 10.1002/jbmr.4311. PMID: 33877707.
Selvaraj NV et al. 2026. Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study. Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr.2026.v16.i05.7314. PMID: 42130995.
Martineau C et al. 2018. Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2. The Journal of clinical investigation. 128(8). DOI: 10.1172/jci98093. PMID: 30010626.
Martineau C et al. 2020. Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair. Journal of orthopaedic translation. 23: 77-88. DOI: 10.1016/j.jot.2020.03.013. PMID: 32518749.
Related reading
Effect of Vitamin D3 Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double‐Blind Controlled Trial
One hundred two patients with a mean age of 29 years (standard deviation 8) were randomized.
Original paper ↗Read more →TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis
Herein, the effects of calcitriol on cultured skeletal muscle primary fibroblasts of male C57BL/6 mice (aged 1 month old) were investigated.
Original paper ↗Read more →Vitamin D, Regenerative Signalling and the Limits of Repair: Full Evidence Review
Examine progenitor-cell signalling, vitamin D metabolites and injury timing, and why experimental regeneration does not establish clinical benefit.
Read more →Inflammation: and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells
Available drugs aim to suppress gut inflammation.
Original paper ↗Read more →Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages
Dysferlin-deficient muscle contained an excess of M1 macrophage markers, compared with WT, and regenerated poorly in response to toxin injury.
Original paper ↗Read more →Vitamin D, Injury Recovery and Inflammation Resolution: Full Evidence Review
Review burn and fracture trials alongside repair mechanisms, showing positive, null and adverse findings and the importance of inflammation timing.
Read more →Vitamin D, Injury Recovery and Inflammation Resolution: Study Summary
A summary of vitamin D burn and fracture studies, with mixed repair outcomes and evidence on the timing of inflammatory responses.
Read more →A comparative study of the injury patterns and inflammatory response between suicidal and unintentional falls from height in Germany
This study aims to analyse injury patterns, inflammatory responses and complication rates in people who have jumped to their death, compared to those who have fallen unintentionally.
Original paper ↗Read more →Effects of macro: and micronutrient intake on bone mineral density, osteoporotic fracture risk, inflammation, and functional rehabilitation outcomes in orthopedic patients: a systematic review and meta-analysis
The systematic review examined 95 studies which were organized into seven distinct outcome domains.
Original paper ↗Read more →Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study
This study aimed to investigate the association between platelet indices and the derived systemic immune inflammation index (SII) with fracture risk in postmenopausal women.
Original paper ↗Read more →Incidence and clinical course of femoral localized periosteal thickening and atypical femoral fracture over a 10-year period in patients with autoimmune inflammatory rheumatic disease
This cohort study investigated the incidence of LPT and AFF and their clinical courses over 10 yr in patients with autoimmune inflammatory rheumatic diseases (AIRDs) treated with BP and GC.
Original paper ↗Read more →Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues
In consecutive HF patient (n = 1273, mean age 82.9 ± 8.7 years, 73.5% females) demographics, medical history, laboratory parameters, and outcomes were recorded prospectively.
Original paper ↗Read more →Sex hormone-binding globulin increases lumbar fracture risk via bone density, inflammation, and insulin pathways
We investigated whether genetically higher SHBG increases lumbar fracture (LF) risk and identified the biological pathways mediating this effect, including bone mineral density (BMD), C-reactive protein (CRP), and insulin use.
Original paper ↗Read more →Vertebral fractures in patients with inflammatory bowel disease COMPARED with a healthy population: a prospective case-control study
Information about anthropometric parameters, toxins, previous fractures, and parameters related to this disease were evaluated.
Original paper ↗Read more →Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination
Patients with dyskinesia exhibited notably higher IL-6 levels compared to controls, and TNF-α was significantly elevated in both PD patient groups relative to the control group.
Original paper ↗Read more →Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy
This study aimed to analyze their long-term use in patients with DTC.
Original paper ↗Read more →Implementation of fracture risk assessment in men with prostate cancer requiring long-term androgen deprivation therapy: a systematic scoping review using the i-PARIHS implementation framework
Androgen deprivation therapy (ADT) is a mainstay of treatment for prostate cancer (PCa) and is associated with increased risks of osteoporosis and fragility fractures.
Original paper ↗Read more →Long-term consumption of liquid dairy products predicts lower fracture risk in aging women: a 25-year follow-up
The study aimed to investigate whether high dairy products consumption is associated with reduced fracture risk in aging women, contributing to understanding this health issue.
Original paper ↗Read more →Longitudinal Evolution of Bone Microarchitecture and Bone Strength in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures: A 5-Year Follow-Up Study Using High Resolution Peripheral Quantitative Computed Tomography
Diabetic bone disease is characterized by an increased fracture risk which may be partly attributed to deficits in cortical bone quality such as higher cortical porosity.
Original paper ↗Read more →Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada
The purpose of this study was to identify barriers to the implementation of evidence-based practices for osteoporosis and fracture prevention in LTC facilities and elicit practical strategies to address these barriers.
Original paper ↗Read more →Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review
Review VITAL, DO-HEALTH and TILDA findings on vitamin D, inflammatory markers, biological ageing and metabolic risk, with causal limits explained.
Read more →Original sources
1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study
Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study.
Publication details
Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 58: e14121. DOI: 10.1590/1414-431x2025e14121. PMID: 40053036.
TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis
Herein, the effects of calcitriol on cultured skeletal muscle primary fibroblasts of male C57BL/6 mice (aged 1 month old) were investigated.
Publication details
Srikuea R et al. 2023. TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis. Scientific reports. 13(1): 13811. DOI: 10.1038/s41598-023-40978-w. PMID: 37612333.
Regulatory role of vitamin D3 on myogenesis and fibrogenesis under Vdr gene silencing and TGF-β1 stimulation in skeletal muscle cells
Watcharanapapan W et al.
Publication details
Watcharanapapan W et al. 2025. Regulatory role of vitamin D3 on myogenesis and fibrogenesis under Vdr gene silencing and TGF-β1 stimulation in skeletal muscle cells. Scientific reports. 15(1): 41599. DOI: 10.1038/s41598-025-25496-1. PMID: 41286086.
Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells
Published in Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds (2025).
Publication details
Song SE et al. 2026. Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells. Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds.2025.07.3564. PMID: 42689044.
1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites
Wasnik S et al. 2018.
Publication details
Wasnik S et al. 2018. 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI insight. 3(17): e98773. DOI: 10.1172/jci.insight.98773. PMID: 30185660.
Effect of Vitamin D3 Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double‐Blind Controlled Trial
One hundred two patients with a mean age of 29 years (standard deviation 8) were randomized.
Publication details
Slobogean GP et al. 2023. Effect of Vitamin D3 Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double-Blind Controlled Trial. JBMR plus. 7(1): e10705. DOI: 10.1002/jbm4.10705. PMID: 36699638.
The Effect of Bolus Vitamin D3 Supplementation on Distal Radius Fracture Healing: A Randomized Controlled Trial Using HR-pQCT
Heyer FL et al. 2021.
Publication details
Heyer FL et al. 2021. The Effect of Bolus Vitamin D3 Supplementation on Distal Radius Fracture Healing: A Randomized Controlled Trial Using HR-pQCT. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 36(8): 1492. DOI: 10.1002/jbmr.4311. PMID: 33877707.
Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study
Published in Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr (2026).
Publication details
Selvaraj NV et al. 2026. Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study. Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr.2026.v16.i05.7314. PMID: 42130995.
Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2
Martineau C et al. 2018.
Publication details
Martineau C et al. 2018. Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2. The Journal of clinical investigation. 128(8). DOI: 10.1172/jci98093. PMID: 30010626.
Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair
Published in Journal of orthopaedic translation. 23: 77-88. DOI: 10.1016/j.jot (2020).
Publication details
Martineau C et al. 2020. Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair. Journal of orthopaedic translation. 23: 77-88. DOI: 10.1016/j.jot.2020.03.013. PMID: 32518749.